In vitro cytotoxic potential of friedelin in human MCF-7 breast cancer cell: Regulate early expression of Cdkn2a and pRb1, neutralize mdm2-p53 amalgamation and functional stabilization of p53
Pandurangan Subash-Babu , David K. Li , Ali A. Alshatwi
{"title":"In vitro cytotoxic potential of friedelin in human MCF-7 breast cancer cell: Regulate early expression of Cdkn2a and pRb1, neutralize mdm2-p53 amalgamation and functional stabilization of p53","authors":"Pandurangan Subash-Babu , David K. Li , Ali A. Alshatwi","doi":"10.1016/j.etp.2017.05.011","DOIUrl":null,"url":null,"abstract":"<div><p>We aimed to explore the cytotoxic and apoptotic effect of friedelin on breast cancer MCF-7 cells. Cytotoxic effect of friedelin on MCF-7 cells was analyzed using MTT, cell and nuclear morphology. The apoptosis mechanism of friedelin on MCF-7 cells was analyzed using real-time PCR. Friedelin potentially inhibit 78% of MCF-7 cell’s growth, the IC<sub>50</sub> value was 1.8<!--> <!-->μM in 24<!--> <!-->h and 1.2<!--> <!-->μM in 48<!--> <!-->h. Friedelin increased ROS significantly and DNA damage was confirmed by tunel assay. We found characteristically 52% apoptotic cells and 6% necrotic cells in PI, AO/ErBr staining after 48<!--> <!-->h treatment with 1.2<!--> <!-->μM of friedelin. Apoptosis was confirmed by significantly (<em>p</em> <!-->≤<!--> <!-->0.001) increased tumor suppressor gene Cdkn1a, pRb2, p53, Nrf2, caspase-3 and decreased Bcl-2, mdm2 & PCNA expression after 48<!--> <!-->h. In conclusion, friedelin effectively inhibit breast cancer MCF-7 cell growth, it was associated with early expression of Cdkn1a, pRb2 and activation of p53 and caspases.</p></div>","PeriodicalId":50465,"journal":{"name":"Experimental and Toxicologic Pathology","volume":"69 8","pages":"Pages 630-636"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.etp.2017.05.011","citationCount":"25","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Toxicologic Pathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0940299317302129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 25
Abstract
We aimed to explore the cytotoxic and apoptotic effect of friedelin on breast cancer MCF-7 cells. Cytotoxic effect of friedelin on MCF-7 cells was analyzed using MTT, cell and nuclear morphology. The apoptosis mechanism of friedelin on MCF-7 cells was analyzed using real-time PCR. Friedelin potentially inhibit 78% of MCF-7 cell’s growth, the IC50 value was 1.8 μM in 24 h and 1.2 μM in 48 h. Friedelin increased ROS significantly and DNA damage was confirmed by tunel assay. We found characteristically 52% apoptotic cells and 6% necrotic cells in PI, AO/ErBr staining after 48 h treatment with 1.2 μM of friedelin. Apoptosis was confirmed by significantly (p ≤ 0.001) increased tumor suppressor gene Cdkn1a, pRb2, p53, Nrf2, caspase-3 and decreased Bcl-2, mdm2 & PCNA expression after 48 h. In conclusion, friedelin effectively inhibit breast cancer MCF-7 cell growth, it was associated with early expression of Cdkn1a, pRb2 and activation of p53 and caspases.
我们旨在探讨弗里德林对乳腺癌MCF-7细胞的细胞毒性和凋亡作用。采用MTT、细胞形态学和细胞核形态学分析了弗里德林对MCF-7细胞的细胞毒作用。采用实时荧光定量PCR技术分析弗里德林对MCF-7细胞的凋亡机制。弗里德林对MCF-7细胞有78%的抑制作用,24 h IC50值为1.8 μM, 48 h IC50值为1.2 μM。1.2 μM弗里德林作用48 h后,PI、AO/ErBr染色中凋亡细胞占52%,坏死细胞占6%。肿瘤抑制基因Cdkn1a、pRb2、p53、Nrf2、caspase-3显著升高(p≤0.001),Bcl-2、mdm2、amp显著降低(p≤0.001)。由此可见,弗里德林能有效抑制乳腺癌MCF-7细胞的生长,其作用与Cdkn1a、pRb2的早期表达以及p53和caspases的激活有关。
期刊介绍:
Cessation. The international multidisciplinary journal is devoted to the publication of studies covering the whole range of experimental research on disease processes and toxicology including cell biological investigations. Its aim is to support progress in the interdisciplinary cooperation of researchers working in pathobiology, toxicology, and cell biology independent of the methods applied. During the past decades increasing attention has been paid to the importance of toxic influence in the pathogenesis of human and animal diseases. This is why Experimental and Toxicologic Pathology meets the urgent need for an interdisciplinary journal felt by a wide variety of experts in medicine and biology, including pathologists, toxicologists, biologists, physicians, veterinary surgeons, pharmacists, and pharmacologists working in academic, industrial or clinical institutions.